Table 2 Comparison between cirrhotic and non-cirrhotic patients regarding baseline patients’ age, biochemical parameters, and Framingham risk score
Baseline parameter | Cirrhotic patients (n = 22) | Non-cirrhotic patients (n = 68) | Student’s t-test | |
|---|---|---|---|---|
t | p | |||
Age (years) | 51.045 ± 10.781 | 45.529 ± 10.267 | 2.164 | 0.033 |
AST (IU/l) | 55.955 ± 35.77 | 45.971 ± 24.985 | 1.457 | 0.149 |
ALT (IU/l) | 70.909 ± 50.675 | 48.824 ± 33.663 | 2.344 | 0.021 |
Albumin (g/dl) | 3.653 ± 0.487 | 4.05 ± 0.393 | −3.881 | <0.001 |
Total bilirubin (mg/dl) | 0.94 ± 0.524 | 0.698 ± 0.308 | 2.663 | 0.009 |
Direct bilirubin (mg/dl) | 0.464 ± 0.233 | 0.349 ± 0.234 | 2.012 | 0.047 |
INR | 1.165 ± 0.156 | 1.087 ± 0.114 | 2.546 | 0.013 |
Hemoglobin (g/dl) | 13.136 ± 1.593 | 13.557 ± 1.548 | −1.101 | 0.274 |
Total leucocyte count (103/μl) | 5.695 ± 1.861 | 7.150 ± 2.487 | −2.520 | 0.014 |
Platelet count (103/μl) | 159.727 ± 71.748 | 219.044 ± 80.611 | −3.077 | 0.003 |
LDL (mg/dl) | 39.001 ± 7.528 | 80.397 ± 19.489 | −9.701 | <0.001 |
Total cholesterol (mg/dl) | 122.409 ± 29.156 | 182.103 ± 33.774 | −7.436 | <0.001 |
HDL (mg/dl) | 40.136 ± 5.375 | 50.544 ± 5.462 | −7.798 | <0.001 |
Lp-PLA2 (ng/ml) | 335.455 ± 74.345 | 320.941 ± 82.023 | 0.737 | 0.463 |
Framingham risk score | 10.323 ± 9.921 | 8.175 ± 8.205 | 1.013 | 0.314 |